As of 19 Nov 2026, Biotia has raised $9M across 1 verified round on record; latest: $9M funding round, announced 1 Oct 2026.
11 sources
The source identifies this as private financing but does not state a round stage, valuation, investors, or headquarters.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $9M $19.4M to date | 2026-10-01 | not stated | No recent discussion |
11 sources [ VERIFIED · CORRECTED ] read against 1 of 11 sources
The source identifies this as private financing but does not state a round stage, valuation, investors, or headquarters. | ||||
Biotia builds clinical metagenomic diagnostic tests and pathogen-genomics software for patients, clinicians, hospitals, laboratories, and public-health researchers facing hard-to-diagnose infections.
Checked against 10 sources on Oct 2
None named.
Also named as backers in company research: Falcon III Ventures, Hyperplane Venture Capital, OCA Ventures, Phoenix Venture Partners, SeedtoB Capital, SK Square Americas, Tau Ventures, SpringTide Ventures